Pre-clinical evaluation of combined CBDA:THCA on nausea in veterinary medicine
Pre-clinical evaluation of combined CBDA:THCA on nausea in veterinary medicine
批准号:
531553-2018
负责人:
Parker, Linda
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Engage Grants Program
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
中文摘要
几千年来,大麻一直被用来治疗恶心和呕吐。事实上,这种症状是第一个获得医用大麻处方批准的症状。大麻中的主要精神活性成分是四氢大麻二酚(THC),大麻中的另一种非精神成分是大麻二酚(CBD),它们都具有抗恶心和止吐的特性。然而,最近,我们的小组已经表明,四氢大麻酚的酸性前体,四氢大麻酚酸(THCA)和CBD, CBD酸(CBDA),在加热后比它们的产品更有效的止吐剂。事实上,THCA是非精神药物,可能比其精神药物更好。事实上,CBDA在减轻恶心和呕吐方面的效力是CBD的1000倍,但对精神运动没有影响。由于CBDA和THCA都存在于生大麻植物中(根据菌株的不同浓度),目前的研究将确定这些化合物的潜在协同作用,一种作用于5-HT1A受体(CBDA),另一种作用于CB1受体(THCA可能是外周的),以减少恶心和呕吐,作为潜在的兽药开发。关于这些化合物的组合对恶心和呕吐的影响的研究很少。在这里,我们建议评估THCA:CBDA剂量的各种组合比单独使用任何一种药物更有效地减轻恶心的潜力。我们还将确定THCA对恶心的影响是由外周还是中枢介导的。这些实验的结果将为接受化疗的伴侣动物提供潜在的新疗法的临床前评估。
英文摘要
Cannabis has been used to treat nausea and vomiting for thousands of years. Indeed, this symptom was the first to receive approval for medical marijuana prescriptions. The primary psychoactive ingredient in cannabis is tetrahydrocannabidiol (THC) and another non-psychotropic ingredient in cannabis is cannabidiol (CBD) which both have anti-nausea and anti-emetic properties. However, recently, our group has shown that the acidic precursors to THC, THC-acid (THCA), and to CBD, CBD-acid (CBDA), are much more potent anti-nausea agents then their products after heating. Indeed, THCA is non-psychotropic and may be a better treatment than its psychotropic product. Indeed, CBDA is 1000 times more potent in reducing nausea and vomiting than CBD, but has no psychomotor effects. Since CBDA and THCA are both present (at various concentrations depending upon strain) in the raw cannabis plant, the present research will determine the potential synergistic effects of these compounds, one that acts on 5-HT1A receptors (CBDA) and the other which acts on CB1 receptors (THCA possibly peripherally) to reduce nausea and vomiting for potential development as veterinary medicines. There has been very little research on the effects of combinations of these compounds on nausea and vomiting. Here we propose to evaluate the potential of various combinations of THCA:CBDA doses to more effectively reduce nausea than either agent on its own. We will also determine if the effects of THCA on nausea are peripherally or centrally mediated. The results of these experiments will provide pre-clinical evaluation of potential new therapies for companion animals undergoing chemotherapy treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2022
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2021
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2020
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2019
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$10.93万
-
财政年份:2019
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$14.57万
-
财政年份:2018
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2018
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2017
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$14.57万
-
财政年份:2017
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$14.57万
-
财政年份:2016
-
负责人:Parker, Linda
-
依托单位:
Pre-clinical evaluation of the efficacy of combined THC and CBDA to treat nausea, pain and anxiety in veterinary medicine
-
批准号:476416-2014
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$4.0万
-
财政年份:2016
-
负责人:Parker, Linda
-
依托单位:
Aversion learning in rats and shrews
-
批准号:RGPIN-2016-03629
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.44万
-
财政年份:2016
-
负责人:Parker, Linda
-
依托单位:
Pre-clinical evaluation of the efficacy of combined THC and CBDA to treat nausea, pain and anxiety in veterinary medicine
-
批准号:476416-2014
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$3.97万
-
财政年份:2015
-
负责人:Parker, Linda
-
依托单位:
Conditioned disgust, preference and avoidance
-
批准号:92057-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.13万
-
财政年份:2015
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$14.57万
-
财政年份:2015
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$14.57万
-
财政年份:2014
-
负责人:Parker, Linda
-
依托单位:
Pre-clinical evaluation of the efficacy of combined THC and CBDA to treat nausea in veterinary medicine
-
批准号:470199-2014
-
项目类别:Engage Grants Program
-
资助金额:$1.82万
-
财政年份:2014
-
负责人:Parker, Linda
-
依托单位:
Conditioned disgust, preference and avoidance
-
批准号:92057-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.13万
-
财政年份:2014
-
负责人:Parker, Linda
-
依托单位:
Conditioned disgust, preference and avoidance
-
批准号:92057-2008
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.13万
-
财政年份:2013
-
负责人:Parker, Linda
-
依托单位:
Behavioural Neuroscience
-
批准号:1000228388-2012
-
项目类别:Canada Research Chairs
-
资助金额:$10.93万
-
财政年份:2013
-
负责人:Parker, Linda
-
依托单位:
国内基金
海外基金
登录
查看更多内容
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
自身免疫性T细胞的抗原决定簇在抗肾小球基底膜病发病中的启动机制
-
批准号:81170645
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:崔昭
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: